Pharmaceuticals,Pharmaceuticals sector projects by Aurobindo Pharma in
Project Information
4846
Aurobindo Pharma
Drug Firm Aurobindo Pharma Has Received Final Approval From The US Health Regulator To Manufacture And Market Generic Cefadroxil Oral Suspension USP In The Strengths Of 250mg/5ml And 500mg/5ml Used For Treating Bacterial Infections In The US Market. The Product Is The Generic Equivalent Of Warner Chilcott Company Inc's Duricef For Oral Suspension In The Same Strengths. Cefadroxil Oral Suspension Has Been Approved Out Of The Company's Cephalosporin Formulations Manufacturing Facility In Hyderabad. Aurobindo Pharma Is One Of The Leading Indian Pharmaceutical Research Companies That Manufactures And Export Drugs And Formulations Worldwide. The Company Has A Total Of 187 Abbreviated New Drug Application (ANDA) Approvals (160 Final Approvals Including 4 From Aurolife Pharma LLC And 27 Tentative Approvals) From USFDA.
Project Value
Refer document
Pre Project Activities Underway
Not Specified
India
Pharmaceuticals,Pharmaceuticals
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
